Protein-sulfhydryl groups in cellular control mechanisms and cancer.
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000818:Animals; D001152:Arsenicals / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002822:Choriocarcinoma / Q000188:drug therapy; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005260:Female; D005459:Fluorides / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008314:Malonates / Q000627:therapeutic use; D008339:Mandibular Neoplasms / Q000188:drug therapy; D051379:Mice; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D011247:Pregnancy; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012509:Sarcoma / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D014812:Vitamin K / Q000627:therapeutic use
D001152:Arsenicals; D004273:DNA, Neoplasm; D008314:Malonates; D012334:RNA, Neoplasm; D014812:Vitamin K; D006493:Heparin; D005459:Fluorides